Application 020378
- Type
- BLA
- Sponsor
- EMD SERONO
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 020378 | Gonal-f | follitropin alfa | 351(a) | Disc | 2026-08-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GONAL-F | FOLLITROPIN ALFA/BETA | INJECTABLE;SUBCUTANEOUS | 75 IU/VIAL | No | No |
| 002 | GONAL-F | FOLLITROPIN ALFA/BETA | INJECTABLE;SUBCUTANEOUS | 150 IU/VIAL | No | No |
| 003 | GONAL-F | FOLLITROPIN ALFA/BETA | INJECTABLE;SUBCUTANEOUS | 37.5 IU/VIAL | No | No |
| 004 | GONAL-F | FOLLITROPIN ALFA/BETA | INJECTABLE;SUBCUTANEOUS | 1,050 IU/VIAL | No | No |
| 005 | GONAL-F | FOLLITROPIN ALFA/BETA | INJECTABLE;SUBCUTANEOUS | 450 IU/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gonal-f | FOLLITROPIN ALFA | EMD Serono, Inc. | ae85b9c3-e7eb-4981-a5d9-346050e8f189 | 2025-09-02 | Warnings, Adverse reactions | BLA020378 44087-9070 44087-9030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9030 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | NDA | Current |
| 44087-9070 | Gonal-f | follitropin alfa | EMD Serono, Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 76654 | SUPPL | 2023-11-24 |
| 76648 | SUPPL | 2023-11-22 |
| 65812 | SUPPL | 2021-01-04 |
| 65811 | SUPPL | 2021-01-04 |
| 65810 | SUPPL | 2021-01-04 |
| 65803 | SUPPL | 2020-12-31 |
| 65802 | SUPPL | 2020-12-31 |
| 65801 | SUPPL | 2020-12-31 |
| 62260 | APPL | 2020-03-23 |
| 41314 | SUPPL | 2020-03-23 |
| 34573 | SUPPL | 2020-03-23 |
| 24869 | SUPPL | 2020-03-23 |
| 24868 | SUPPL | 2020-03-23 |
| 2423 | SUPPL | 2020-03-23 |
| 2422 | SUPPL | 2020-03-23 |